HEMATOPOIETIC CELL TRANSPLANT
Clinical trials for HEMATOPOIETIC CELL TRANSPLANT explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC CELL TRANSPLANT trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC CELL TRANSPLANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune-Guided drug break could cut infections in transplant patients
Disease control Recruiting nowThis study looks at whether measuring a patient's immune response to cytomegalovirus (CMV) can help decide when to stop the preventive drug letermovir after a stem cell transplant. About 105 transplant recipients at high risk for CMV will have their letermovir dosing adjusted bas…
Matched conditions: HEMATOPOIETIC CELL TRANSPLANT
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New approach may tame dangerous immune reaction after stem cell transplant
Disease control Recruiting nowThis study tests whether giving the immune-suppressing drug tacrolimus earlier than usual can lower the risk of cytokine release syndrome (CRS), a severe inflammatory reaction, after a half-matched stem cell transplant. About 20 adults with blood cancers who are getting their fir…
Matched conditions: HEMATOPOIETIC CELL TRANSPLANT
Phase: PHASE2 • Sponsor: Northside Hospital, Inc. • Aim: Disease control
Last updated May 11, 2026 20:54 UTC
-
New program aims to ease suffering for stem cell transplant patients
Symptom relief Recruiting nowThis study tests a new program called Sentinel that helps doctors provide extra comfort and support to patients receiving stem cell transplants. The program is designed to improve quality of life during a difficult treatment. Researchers will enroll 40 adults to see if the progra…
Matched conditions: HEMATOPOIETIC CELL TRANSPLANT
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 17, 2026 00:45 UTC
-
Online therapy aims to get young transplant patients moving again
Symptom relief Recruiting nowThis study tests whether a 12-week virtual physical therapy program is practical and helpful for children and young adults (ages 8–23) who are at least 100 days past a bone marrow transplant. Participants will have twice-weekly online sessions with a physical therapist and receiv…
Matched conditions: HEMATOPOIETIC CELL TRANSPLANT
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
Brain training may sharpen minds after stem cell transplant
Symptom relief Recruiting nowThis study tests whether a computer brain-training program (Lumosity) can improve memory and thinking in people who have had a stem cell transplant for blood cancer. About 60 survivors, 3 to 6 months after transplant, will either use the program or wait. The goal is to see if the…
Matched conditions: HEMATOPOIETIC CELL TRANSPLANT
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated May 11, 2026 20:39 UTC
-
Can we predict which kids will get sick after transplant? new study aims to find out.
Knowledge-focused Recruiting nowThis study follows 2,000 children who have had or will have a bone marrow or solid organ transplant. Researchers want to see if testing for respiratory viruses before the transplant can help predict who will get a serious respiratory infection in the first year after transplant. …
Matched conditions: HEMATOPOIETIC CELL TRANSPLANT
Sponsor: Arkansas Children's Hospital Research Institute • Aim: Knowledge-focused
Last updated May 17, 2026 00:44 UTC